Vanguard Global Advisers’s Kestra Medical Technologies KMTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$367K Buy
12,967
+5,732
+79% +$146K ﹤0.01% 2235
2026
Q2
$184K Sell
7,235
-2,533
-26% -$53K ﹤0.01% 2530
2026
Q1
$195K Buy
+9,768
New +$230K ﹤0.01% 2451

Other funds holding KMTS

Vanguard Global Advisers's KMTS Position: Q3 2026 in Review

Vanguard Global Advisers increased its Kestra Medical Technologies (KMTS) stake by 79% in Q3 2026, buying an estimated $146K and bringing the position to 12,967 shares worth $367K. The position accounts for ﹤0.01% of the portfolio, ranked #2235.

Vanguard Global Advisers first reported a position in KMTS in Q1 2026 and has held it in 3 quarters since. 122 funds tracked by Wall St. Rank hold KMTS as of Q3 2026.

  • Vanguard Global Advisers held 12,967 shares of Kestra Medical Technologies worth $367K as of Q3 2026.
  • Vanguard Global Advisers bought 5,732 Kestra Medical Technologies shares in Q3 2026, an estimated $146K.
  • Kestra Medical Technologies made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2235 holding.
  • Vanguard Global Advisers first reported a position in Kestra Medical Technologies in Q1 2026 and has held it in 3 quarters since.
  • 122 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.